* Gamida Cell Ltd GMDA.OQ GMDA.O is expected to show no
change
in quarterly revenue when it reports results on March 1
(estimated).
* Refinitiv's mean analyst estimate for Gamida Cell Ltd is
for a
loss of 40 cents per share. For the same quarter last year, the
company reported a loss of 68 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Gamida Cell
Ltd
is $14, about 76.7% above its last closing price of $3.26.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 -0.49 -0.48 -0.33 Beat 31.3
Jun. 30 2021 -0.39 -0.40 -0.36 Beat 10.4
Mar. 31 2021 -0.40 -0.40 -0.31 Beat 22.2
Dec. 31 2020 -0.34 -0.34 -0.68 Missed -98.1
Sep. -0.31 -0.31 -0.30 Beat 4.3
30 2020
Jun. 30 2020 -0.30 -0.30 -0.37 Missed -24.7
Mar. 31 2020 -0.45 -0.45 -0.27 Beat 39.7
Dec. 31 2019 -0.34 -0.34 -0.31 Beat 9.9
This summary was machine generated February 25 at 16:16 GMT.
All figures in US dollars unless otherwise stated